Company Performance Metrics
NIR Diagnostics specializes in the development of leading edge medical diagnostic instruments. NIR is leveraging its proprietary near infrared light technology and its expertise of optics, electronics and mathematics to create, develop and license devices to monitor key blood analytes accurately, rapidly and without the need for chemical reagents.
They are focused on value creation through the near-term commercialization of products and, in the longer-term, through the formation of partnerships to develop their technology for higher-value product opportunities. Their lead product is HemoNIR™, a hand-held in-vitro point-of-care device to measure functional and non-functional hemoglobin.
The primary research goal of the company remains the completion of GlucoNIR™, a diagnostic device for non-invasive monitoring of glucose levels in the blood, aimed at the $4.5 billion North American glucose monitoring market. The Company is also developing devices with applications for the cardiovascular market.
NIR Diagnostics Inc. became a publicly traded company in 1996 and is located in Campbellville, Ontario.
